Try our Advanced Search for more refined results
Horizon Therapeutics PLC
-
Filed: May 01, 2024 | Entered: May 01, 2024 In Re: Tepezza Marketing, Sales Practices, and Products Liability Litigation
890(Other Statutory Actions) | Illinois Northern
Minute
MINUTE entry before the Honorable Thomas M. Durkin: Oral argument held on 5/1/2024. The first bellwether trial will begin on 3/9/2026. By 5/10/2024, the parties should submit an agreed proposed schedule or, if they cannot reach agreement, a comparison of their proposed schedules in the same format as R. 139-2. The Court will set a date for the next status conference following the 5/10/2024 submission. Mailed notice. (ecw, ) (Entered: 05/01/2024)
-
Filed: April 30, 2024 | Entered: April 30, 2024 In Re: Tepezza Marketing, Sales Practices, and Products Liability Litigation
890(Other Statutory Actions) | Illinois Northern
Minute
MINUTE entry before the Honorable Thomas M. Durkin: A combined in-person staus hearing with Judge Weisman and Judge Durkin is set for 5/1/2024 at 1:00 p.m. in courtroom 1441. Mailed notice. (ecw, ) (Entered: 04/30/2024)
-
Filed: April 30, 2024 | Entered: April 30, 2024 Abriola v. Horizon Therapeutics USA, Inc.
367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability) | Illinois Northern
Attorney
ATTORNEY Appearance for Plaintiff Diane Abriola by Melanie S Bailey (Bailey, Melanie) (Entered: 04/30/2024)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login